Raltegravir

Raltegravir · First-generation integrase inhibitor

With other antiretrovirals for HIV-1 in treatment-naive and experienced patients

400mg tablets Twice daily oral Insurance Category B

Therapeutic Areas

HIV & Infectious

Marketed Products

Raltegravir

Modality

Raltegravir

Core Products

Bictegravir/FTC/TAF · Single-tablet triple regimen

Dolutegravir · Second-generation integrase strand transfer inhibitor

Emtricitabine · Nucleoside reverse transcriptase inhibitor

Creating a Healthier Future Together

Explore our innovative products and pipeline, and see how Poseidon brings hope to patients worldwide